The new name for NASH is MASH, which stands for Metabolic Dysfunction-Associated Steatohepatitis. Medical experts introduced this updated term in 2023 as part of a broader effort to improve the way fatty liver diseases are named and understood. The change also included renaming NAFLD (Nonalcoholic Fatty Liver Disease) to MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease).
If you have seen NASH in an older medical report, research paper, or doctor’s note, you may wonder whether it refers to a different condition. It does not. MASH describes the same liver disease previously called NASH.
The updated terminology places greater focus on metabolic health rather than alcohol use. This guide explains what the new name means, why the terminology changed, and what patients should know about the updated medical terms.
What Is the New Name for NASH?
The new name for NASH is MASH (Metabolic Dysfunction-Associated Steatohepatitis).
NASH was short for Nonalcoholic Steatohepatitis. Doctors used this term to describe a form of fatty liver disease that causes fat buildup, inflammation, and liver cell damage.
The updated name, MASH, reflects the connection between this condition and metabolic problems. These may include:
- Excess body weight or obesity.
- Type 2 diabetes.
- Insulin resistance.
- High blood pressure.
- Abnormal cholesterol levels.
- Other metabolic risk factors.
MASH is not a completely new disease. It is the updated medical name for the condition previously known as NASH.
The change helps doctors and researchers use language that better describes the underlying health factors associated with the disease.
What Does MASH Stand For?
MASH stands for Metabolic Dysfunction-Associated Steatohepatitis.
Each part of the name describes an important feature of the condition.
- Metabolic: Refers to the body’s processes for managing energy, blood sugar, fats, and other substances.
- Dysfunction: Means that some of these processes are not working properly.
- Associated: Indicates a connection with metabolic health problems.
- Steato: Refers to fat buildup in the liver.
- Hepatitis: Means inflammation of the liver.
The complete name describes a liver condition involving fat accumulation and inflammation associated with metabolic dysfunction.
The terminology also helps distinguish MASH from other liver conditions that may cause similar symptoms or damage.
Why Was NASH Renamed to MASH?
The name changed because medical experts wanted terminology that better reflected the causes and characteristics of the disease.
The older term NASH included the word “nonalcoholic.” This described the condition mainly by what was not causing it: significant alcohol consumption.
Experts recognized that this approach had limitations.
1. The Old Name Focused on Alcohol
The term NASH emphasized the absence of alcohol-related liver disease.
It did not clearly explain the metabolic factors commonly associated with the condition.
The updated name gives more attention to these underlying factors.
2. Metabolic Health Plays an Important Role
Many people with this condition have metabolic problems such as insulin resistance, obesity, or type 2 diabetes.
MASH reflects this connection in its name.
3. The New Terminology Is More Inclusive
The older terminology could create confusion about the role of alcohol and other health factors.
The updated naming system provides a clearer medical framework for describing different types of fatty liver disease.
4. Medical Research Needed Consistent Language
Researchers and healthcare professionals needed terminology that could be used more consistently across clinical studies, patient care, and medical communication.
The updated names help create a more unified approach.
What Is the Difference Between NASH and MASH?
NASH and MASH refer to the same liver condition. The main difference is the terminology, not the disease itself.
| Feature | NASH | MASH |
|---|---|---|
| Full name | Nonalcoholic Steatohepatitis | Metabolic Dysfunction-Associated Steatohepatitis |
| Medical status | Previous terminology | Updated terminology |
| Fat buildup | Present | Present |
| Liver inflammation | Present | Present |
| Liver damage | Possible | Possible |
| Main naming focus | Nonalcoholic status | Metabolic dysfunction |
A person who was diagnosed with NASH before the terminology changed may now see MASH used in newer medical materials.
The name change does not automatically mean that the person’s condition has improved, worsened, or changed into another disease.
The diagnosis still describes the same underlying liver condition.
What Is the New Name for NAFLD?
The new name for NAFLD is MASLD, which stands for Metabolic Dysfunction-Associated Steatotic Liver Disease.
NAFLD was the previous term for a group of conditions involving excess fat in the liver that were not primarily caused by heavy alcohol consumption.
The updated terminology places greater emphasis on metabolic dysfunction.
The two main name changes are:
- NAFLD became MASLD.
- NASH became MASH.
These changes are part of the same medical terminology update introduced in 2023.
MASLD is the broader category. MASH is a more specific condition within that category.
What Is the Difference Between MASLD and MASH?
MASLD and MASH are related terms, but they do not mean exactly the same thing.
MASLD is the broader condition, while MASH describes a more advanced form involving liver inflammation and cell injury.
A person can have MASLD without having MASH.
| Feature | MASLD | MASH |
|---|---|---|
| Full name | Metabolic Dysfunction-Associated Steatotic Liver Disease | Metabolic Dysfunction-Associated Steatohepatitis |
| Liver fat | Present | Present |
| Inflammation | Not required | Present |
| Liver cell injury | Not required | Present |
| Relationship | Broad disease category | Specific form within MASLD |
MASLD includes people who have excess liver fat and at least one relevant cardiometabolic risk factor.
MASH involves additional liver inflammation and damage to liver cells.
This distinction matters because not everyone with fatty liver disease develops inflammation or significant liver injury.
What Are the Symptoms of MASH?
MASH often develops without noticeable symptoms, especially during its early stages.
Many people discover the condition through routine blood tests, imaging, or medical evaluations for other health concerns.
Some possible symptoms include:
- Fatigue or unusual tiredness.
- Discomfort in the upper-right side of the abdomen.
- A general feeling of weakness.
- Unexplained abdominal discomfort.
These symptoms are not specific to MASH. Other health conditions can cause similar problems.
Advanced liver disease may produce more noticeable signs, such as:
- Swelling in the legs or ankles.
- Abdominal swelling caused by fluid buildup.
- Yellowing of the skin or eyes.
- Easy bruising.
- Confusion or changes in mental alertness.
These symptoms require medical attention. Sudden confusion, vomiting blood, or severe abdominal swelling needs urgent medical evaluation.
A person can have MASH without experiencing any obvious warning signs.
What Causes MASH?
MASH develops when excess fat accumulates in the liver alongside inflammation and liver cell injury.
Metabolic dysfunction is closely linked to this process.
Several factors can increase the risk.
Insulin Resistance
Insulin helps the body control blood sugar levels.
And Insulin resistance occurs when the body’s cells do not respond properly to insulin. This can contribute to abnormal fat storage and increased fat buildup in the liver.
Obesity
Excess body fat, especially fat around the abdomen, is associated with a higher risk of metabolic liver disease.
Not everyone with MASH has obesity. People with a normal body weight can also develop the condition.
Type 2 Diabetes
Type 2 diabetes is an important risk factor for MASH.
High blood sugar and insulin resistance can affect how the body processes and stores fat.
High Cholesterol and Triglycerides
Abnormal blood fat levels may contribute to metabolic dysfunction.
High triglycerides and unhealthy cholesterol levels are commonly associated with fatty liver disease.
High Blood Pressure
The High blood pressure is another metabolic risk factor.
It often occurs alongside insulin resistance, excess abdominal fat, and other conditions linked to liver health.
How Is MASH Diagnosed?
Doctors use a combination of medical history, blood tests, imaging, and other assessments to evaluate possible MASH.
No single routine blood test can confirm every case.
1. Medical History and Physical Examination
A healthcare professional may ask about:
- Diabetes history.
- Body weight and recent changes.
- Alcohol consumption.
- Blood pressure.
- Cholesterol levels.
- Medications.
- Other medical conditions.
These details help identify possible risk factors.
2. Blood Tests
Blood tests can help doctors assess liver health.
Common tests include:
- ALT (Alanine Aminotransferase).
- AST (Aspartate Aminotransferase).
- Platelet count.
- Blood glucose.
- HbA1c.
- Lipid profile.
Normal liver enzyme levels do not always rule out MASH or significant liver damage.
3. Imaging Tests
Imaging can help identify fat buildup and assess liver structure.
Common options include:
- Ultrasound.
- MRI.
- MRI-based fat measurement.
- Transient elastography.
Some imaging methods can also help estimate liver stiffness, which may indicate scarring.
4. Liver Biopsy
A liver biopsy involves collecting a small tissue sample for examination.
It can help identify fat accumulation, inflammation, liver cell injury, and fibrosis.
Doctors may recommend a biopsy when other tests do not provide enough information or when confirming the diagnosis is important for treatment decisions.
Not everyone with suspected MASH needs a liver biopsy.
Can MASH Cause Liver Damage?
Yes. MASH can cause ongoing liver damage, especially when inflammation continues over time.
The condition may progress through several stages.
Simple Fatty Liver
Fat accumulates inside liver cells.
This stage does not necessarily involve significant inflammation or liver cell injury.
MASH
Fat buildup occurs alongside inflammation and liver cell damage.
This is the stage previously known as NASH.
Liver Fibrosis
Repeated liver injury can cause scar tissue to develop.
This process is called fibrosis.
The amount of scarring can range from mild to severe.
Cirrhosis
Advanced fibrosis can lead to cirrhosis.
The liver develops extensive scarring, which can affect its ability to function properly.
Liver Cancer
People with advanced liver disease and cirrhosis have an increased risk of liver cancer.
Some people with MASH-related liver cancer may develop it without established cirrhosis, although this is less common.
Not everyone with MASH progresses to cirrhosis. Disease progression varies from person to person.
Is MASH the Same as Fatty Liver Disease?
MASH is a type of fatty liver disease, but the terms are not interchangeable.
Fatty liver disease describes a broader group of conditions involving excess fat in the liver.
MASH is a specific form involving fat buildup, inflammation, and liver cell injury.
A person can have fatty liver without having MASH.
The distinction is important because inflammation and liver cell damage can increase the risk of progressive liver disease.
Can MASH Be Reversed?
MASH may improve with appropriate treatment and changes in metabolic health.
Some people can experience reduced liver fat, less inflammation, and improvement in liver injury.
The results depend on factors such as disease stage, overall health, and the presence of other medical conditions.
Treatment plans may include:
- Gradual weight loss when medically appropriate.
- A balanced eating pattern.
- Regular physical activity.
- Better blood sugar control.
- Management of high cholesterol.
- Control of high blood pressure.
- Treatment of related medical conditions.
People with significant liver fibrosis may need specialist care and regular monitoring.
A healthcare professional can help determine which changes and treatments are appropriate for an individual’s condition.
What Is the Treatment for MASH?
MASH treatment focuses on improving liver health, addressing metabolic risk factors, and reducing the risk of further liver damage.
The right approach depends on the severity of the condition.
Lifestyle Changes
Healthy lifestyle habits are an important part of managing MASH.
Doctors may recommend:
- Eating more vegetables and whole foods.
- Choosing high-fiber foods.
- Limiting sugary drinks.
- Reducing highly processed foods.
- Avoiding excess calories.
- Staying physically active.
- Maintaining a healthy weight.
For people who are overweight, gradual and sustained weight loss may improve liver health.
Managing Diabetes
People with diabetes may need treatment to improve blood sugar control.
Better glucose management can support overall metabolic health.
Managing Cholesterol
High triglycerides and unhealthy cholesterol levels should be addressed as part of a complete treatment plan.
Medication
Certain medications may be appropriate for selected patients with MASH.
In the United States, resmetirom (Rezdiffra) received FDA approval in 2024 for adults with noncirrhotic NASH and moderate to advanced liver fibrosis, alongside diet and exercise.
The condition is now commonly referred to as MASH, although the original terminology may still appear in the drug’s official labeling.
Medication suitability depends on the patient’s medical history and disease stage. A liver specialist can explain available options.
When Did NASH Officially Become MASH?
The updated terminology was introduced in June 2023.
An international group of liver experts, medical organizations, and patient representatives worked together to develop the new naming system.
The goal was to create more accurate, inclusive, and medically useful names for fatty liver diseases.
The update introduced two major changes:
- NAFLD was renamed MASLD.
- NASH was renamed MASH.
The new terminology is now widely used in medical research, professional guidance, and healthcare discussions.
Older medical records and research papers may still use NAFLD and NASH. Both terms remain recognizable.
Frequently Asked Questions
1. What is the new name for NASH?
The new name for NASH is MASH, which stands for Metabolic Dysfunction-Associated Steatohepatitis. It is the updated medical term for the same condition previously called Nonalcoholic Steatohepatitis.
2. Is MASH the same as NASH?
Yes. MASH and NASH describe the same liver condition. The medical terminology changed in 2023 to place greater emphasis on metabolic dysfunction rather than the absence of alcohol consumption.
3. What does MASH stand for in medical terms?
MASH stands for Metabolic Dysfunction-Associated Steatohepatitis. It describes a condition involving excess fat in the liver, inflammation, and liver cell injury associated with metabolic dysfunction.
4. What is the new name for NAFLD?
The new name for NAFLD is MASLD, which means Metabolic Dysfunction-Associated Steatotic Liver Disease. It is the broader category of fatty liver disease associated with metabolic risk factors.
5. Is MASH a serious liver disease?
MASH can become serious if inflammation and liver injury continue over time. It may lead to fibrosis, cirrhosis, and other complications. Many people do not develop advanced liver disease, and early management can help reduce the risk of progression.
6. Can a person have MASLD without MASH?
Yes. MASLD is the broader category of metabolic dysfunction-associated fatty liver disease. MASH is a specific form that includes liver inflammation and cell injury. Not everyone with MASLD develops MASH.
7. Does MASH mean that a person has liver cirrhosis?
No. MASH does not automatically mean cirrhosis is present. It can occur without advanced scarring. Cirrhosis is a later stage of liver damage that may develop in some people over time.
8. Should someone with an old NASH diagnosis change their medical records?
The terminology has changed, but patients do not need to assume their previous diagnosis is incorrect. A healthcare professional can explain how the updated MASH terminology applies to their medical records and current condition.
Conclusion
The new name for NASH is MASH (Metabolic Dysfunction-Associated Steatohepatitis). This terminology update was introduced in 2023 to better describe the metabolic factors linked to fatty liver disease.
MASH and NASH refer to the same condition. The broader term NAFLD has also been replaced by MASLD.
Understanding these updated names can make medical reports, research, and conversations with healthcare professionals easier to follow. Anyone with a previous NASH diagnosis can discuss the updated terminology and appropriate liver health monitoring with their doctor.

Mr Zain created NameMeaningBase to help people explore the beauty and significance of names. From popular baby names to unique names and their origins, I strive to deliver useful insights that inspire curiosity and help readers find names with meaning.